Victoria Gross, MD
Dermatology · Richmond, VANPI 1568558625
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 736 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,922 and has fallen 63.6% since, to $1,064 in 2025.
Across 736 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$1K
- UCB, Inc.$869
- Amgen$770
- Sanofi$732
- Sun Pharmaceutical Industries Inc.$632
- plus $6K from 30 others
What the payments were for
- Food & beverage$12,96996%
- Education$5684%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 151 | $2,658 |
| Johnson & Johnson | 80 | $1,402 |
| UCB, Inc. | 41 | $869 |
| Amgen | 29 | $770 |
| Sanofi | 29 | $732 |
| Sun Pharmaceutical Industries Inc. | 28 | $632 |
| Pfizer | 34 | $577 |
| LEO Pharma Inc. | 34 | $577 |
| Arcutis Biotherapeutics, Inc. | 37 | $563 |
| Regeneron Healthcare Solutions, Inc. | 22 | $562 |
| Novartis | 35 | $539 |
| Dermavant Sciences, Inc. | 50 | $536 |
| Hill Dermaceuticals, Inc. | 1 | $468 |
| Incyte Corporation | 18 | $436 |
| Lilly USA, LLC | 25 | $409 |
| Galderma Laboratories, L.p. | 39 | $389 |
| E.r. Squibb & Sons, L.L.C. | 14 | $240 |
| VYNE Pharmaceuticals Inc. | 12 | $236 |
| Mayne Pharma Commercial LLC | 8 | $136 |
| EPI Health, LLC | 6 | $134 |
| Mallinckrodt Hospital Products Inc. | 3 | $77 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $69 |
| Almirall LLC | 3 | $68 |
| Bristol Myers Squibb | 4 | $58 |
| Verrica Pharmaceuticals Inc. | 3 | $50 |
| Encore Dermatology Inc. | 3 | $47 |
| Mission Pharmacal Company | 3 | $46 |
| Aclaris Therapeutics, Inc. | 3 | $46 |
| Promius Pharma LLC | 2 | $42 |
| Prugen, Inc. Pharmaceuticals | 6 | $38 |
| Journey Medical Corporation | 1 | $29 |
| Organon | 3 | $27 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Merck | 1 | $20 |
| Genentech USA, Inc. | 1 | $18 |
| Sebela Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tolak$468
How this compares
$13,537 in reported general payments places this provider in the 85th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 21 | $96,090 |
| Taltz AutoinjectorIxekizumab | 12 | $74,935 |
| Clobetasol Propionate | 57 | $4,239 |
| Fluocinonide | 100 | $3,296 |
| CiclopiroxCiclopirox Olamine | 111 | $2,617 |
| Metronidazole | 44 | $2,251 |
| Clindamycin Phosphate | 34 | $1,987 |
| Ketoconazole | 109 | $1,797 |
| Azelaic Acid | 23 | $1,617 |
| Dutasteride | 37 | $1,610 |
| Doxycycline Hyclate | 58 | $1,602 |
| Fluorouracil | 17 | $1,242 |
| ValacyclovirValacyclovir Hcl | 48 | $1,119 |
| Triamcinolone Acetonide | 197 | $1,041 |
| Mupirocin | 139 | $899 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Richmond
- Mohammed DanyRichmond$74K
- Suzanne PeckRichmond$51K
- Melissa KingRichmond$15K
- Margaret TerhuneRichmond$13K
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Diego DasilvaVirginia Beach$1.1M
- Vishal PatelLeesburg$719K
- Cyndi Torosky TommasoVirginia Beach$717K
- Daniel HurdBlacksburg$545K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.